
Mega Doctor News
A healthy heart rhythm is essential for keeping blood, oxygen and nutrients flowing efficiently throughout the body.
When that rhythm becomes irregular, it can affect the heart’s ability to function properly and increase the risk of serious health complications.
More than 14 million Americans live with heart rhythm disorders, according to the Centers for Disease Control and Prevention. These conditions, known as arrhythmias, contribute to more than 300,000 deaths each year nationwide.
For patients with severe rhythm abnormalities, a pacemaker can be a lifesaving solution, helping regulate the heart’s electrical activity and maintain a safe, consistent heartbeat.
“Pacemakers are designed to monitor the heart’s rhythm and deliver electrical impulses when needed to help it beat at an appropriate rate,” said Federico E. Azpurua, MD, FACC, a board-certified interventional cardiologist with South Texas Health System (STHS) Clinics. “In addition to reducing the risk of serious complications, these devices can significantly improve a patient’s quality of life by relieving symptoms such as dizziness, fatigue, fainting episodes and shortness of breath.”
Patients across the Rio Grande Valley who require advanced treatment for heart rhythm disorders can continue to rely on STHS Heart for nationally recognized cardiovascular care.
Healthgrades, the leading online resource for information about physicians and hospitals, has named STHS Heart a Five-Star Recipient for Pacemaker Procedures in 2027 for the second consecutive year, recognizing the facility’s superior clinical outcomes and commitment to patient care.
“This recognition reflects the dedication of our physicians, nurses and clinical teams to providing exceptional cardiovascular care to the communities we serve,” says Brenda Ivory, Chief Executive Officer, STHS Heart. “For more than three decades, STHS Heart has remained committed to advancing heart care in the Rio Grande Valley through innovative treatments, advanced technology and a patient-centered approach. Earning this distinction from Healthgrades for a second straight year reinforces our commitment to delivering safe, high-quality care and achieving the best possible outcomes for our patients.”
The Five-Star Rating for Pacemaker Procedures adds to a growing list of national accolades earned by STHS Heart for cardiovascular excellence.
The facility recently received Healthgrades’ 2027 Specialty Excellence Awards for Cardiac Care, Coronary Intervention and Cardiology Services, making it the only hospital in the Rio Grande Valley and one of just nine hospitals in Texas to earn all three distinctions.
Additionally, STHS Heart was named one of America’s 100 Best Hospitals for Coronary Intervention for the second consecutive year, placing it among the nation’s top 5% of hospitals for coronary interventional procedures. The hospital also earned Five-Star Ratings for Defibrillator Procedures, Treatment of Heart Attack and Coronary Interventional Procedures in 2027.
As part of its annual analysis, Healthgrades evaluated risk-adjusted mortality and complication rates for more than 30 common conditions and procedures at approximately 4,500 hospitals nationwide to identify top-performing facilities.
According to Healthgrades, if all hospitals had performed at the level of Five-Star recipients during the 2023-2025 study period, an estimated 227,229 lives could have been saved and 158,138 complications could have been avoided.*
“Finding a hospital that excels in a given procedure or treatment can transform a patient’s health trajectory,” said Alana Biggers, MD, MPH, medical advisor, Healthgrades. “We’re proud to recognize STHS Heart for its top-tier performance in pacemaker procedures and commend its team for delivering exceptional patient outcomes when it matters most.”
To learn more about the award-winning cardiovascular services available at STHS Heart, visit https://southtexashealthsystemheart.com.
To learn more about how Healthgrades determines the top hospitals for specialty care, view the complete 2027 Specialty Excellence Awards and Ratings Methodology.
*Statistical averages are based on Healthgrades’ analysis of MedPAR data for years 2023-2025 and represent three-year estimates for Medicare patients only.














